Form 4: HCA Healthcare EVP and CFO Mike Marks Reports Acquisition of Stock Appreciation Rights

Sentiment:

SEC Form 4 Filing


Mike Marks, EVP and CFO of HCA Healthcare, reports the acquisition of stock appreciation rights and a gift of common stock.

Summary

  • On May 1, 2024, Mike Marks, EVP and CFO of HCA Healthcare, filed a Form 4 disclosing changes in beneficial ownership.
  • The report details the acquisition of 9,096 stock appreciation rights (SARs) on April 29, 2024, at an exercise price of $311.42.
  • These SARs vest in four equal annual installments starting April 29, 2025.
  • Marks also reported a gift of 566 shares of common stock on May 1, 2024.
  • Following these transactions, Marks directly owns 2,237 shares of common stock and indirectly owns 40,990 shares through the MAM 2020 Trust and 26,500 shares through the LAM 2020 Trust.
  • Marks has a Power of Attorney designating John M. Franck II, Natalie Harrison Cline, and Kevin A. Ball as attorneys-in-fact.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing. The acquisition of SARs is generally viewed as a positive sign, aligning management's interests with shareholders, but it's a standard practice.

Positives

  • The acquisition of stock appreciation rights aligns the executive's interests with the company's long-term performance.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the stock appreciation rights.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. This filing indicates changes in the holdings of a key executive at HCA Healthcare.

Comparison to Industry Standards

  • Executive compensation packages often include stock appreciation rights to align management's interests with shareholder value.
  • The vesting schedule of the SARs (four equal annual installments) is a common practice in executive compensation.
  • Comparing the size of the SAR grant to those of executives at comparable healthcare companies (e.g., Universal Health Services, Tenet Healthcare) would provide further context.

Stakeholder Impact

  • The acquisition of stock appreciation rights can positively impact shareholders by aligning management's interests with the company's performance.
  • The gift of common stock has a negligible impact on stakeholders.

Key Dates

DateDescription
2023-01-05Date of Power of Attorney execution.
2024-04-29Transaction date for stock appreciation rights acquisition.
2024-04-29First vesting date for stock appreciation rights (annual installments).
2024-05-01Date of gift of common stock and filing date of Form 4.
2025-04-29First vesting date for stock appreciation rights.
2034-04-29Expiration date for stock appreciation rights.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.